LINCOMYCIN SPECTINOMYCIN/AGROSEED CANDILIDIS 5%+10% ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ ΓΙΑ ΧΟΙΡΟΥΣ
LINCOMYCIN SPECTINOMYCIN/AGROSEED CANDILIDIS 5%+10% ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ ΓΙΑ ΧΟΙΡΟΥΣ
Authorised
- Lincomycin hydrochloride
- SPECTINOMYCIN HYDROCHLORIDE
Product identification
Medicine name:
LINCOMYCIN SPECTINOMYCIN/AGROSEED CANDILIDIS 5%+10% ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ ΓΙΑ ΧΟΙΡΟΥΣ
Active substance:
- Lincomycin hydrochloride
- SPECTINOMYCIN HYDROCHLORIDE
Target species:
-
Pig
Route of administration:
-
Intramuscular use
-
Subcutaneous use
Product details
Active substance and strength:
-
Lincomycin hydrochloride50.00/milligram(s)1.00millilitre(s)
-
SPECTINOMYCIN HYDROCHLORIDE100.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Pig
-
Meat and offal21day
-
-
-
Subcutaneous use
-
Pig
-
Meat and offal21day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01FF52
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Greece
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Complete application (stand-alone)
Marketing authorisation holder:
- Candilidis S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Alfasan International B.V.
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 3242/27-01-2000/K-0125401
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
How useful was this page?: